This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Breslow thickness

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The Breslow thickness is the best indicator of prognosis in stage I malignant melanoma, that is with no metastases. It is measured in millimetres from the overlying granular layer of the epidermis to the deepest easily identifiable tumour cells with an ocular micrometer.

Three prognostic groups are identifiable:

Prognosis 5 year survival

  • less than 1.5 mm good 93%
  • 1.5 - 3.49 mm intermediate 67%
  • more than 3.5 mm poor 37%

  • overall 62%

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.